HEALTHCARE GLOB. ENT. LTD Fair Value
HCG · Healthcare · Current price ₹703.75
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹78 | 3% ROE fading to 13% over ~3 yrs, on ₹89 book |
| Relative P/E | ₹60 | EPS × 65.0 peer-median P/E |
| Graham floor | ₹43 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | ₹822 | Street consensus 12-month target price |
Is HEALTHCARE GLOB. ENT. LTD undervalued?
DocStoX estimates the fair value of HEALTHCARE GLOB. ENT. LTD at ₹203 per share, versus the current market price of ₹704. That puts the stock about -71.2% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹78), Relative P/E (₹60), Graham floor (₹43), Analyst target (₹822). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹43 (bear) to ₹203 (base) to ₹822 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on HEALTHCARE GLOB. ENT. LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.